Abstract
Inborn errors of metabolism (IEMs) with neurological consequences encompass a wide range of inherited genetic disorders. These disorders can affect the brain, nervous system, and muscles along with other organ systems. The signs and symptoms are often non-specific but can also include more specific neurological symptoms such as seizures, ataxia, or other movement disorders. Many disorders present in the newborn period and are often identified through newborn screening (NBS) programs. Commonly available laboratory tests can suggest specific categories of metabolic disorders such as amino acid, organic acid, or acylcarnitine abnormalities. Enzymatic and/or molecular genetic testing are used to confirm specific diagnoses. Findings on brain magnetic resonance imaging (MRI) or computed tomography (CT) scans and other imaging studies, as well as biopsies can also be specific to various disorders. This chapter provides an approach to diagnosing these groups of inborn errors of metabolism, focusing on those disorders that can present with neurological symptoms. Key points (potential neurological signs/symptoms, other signs/symptoms, laboratory abnormalities, diagnostic tests, and management) are included. Such disorders are typically managed by biochemical genetic specialists but include many other specialists as well. Most importantly, the initial suspicion of an inborn error of metabolism and implementation of early management and treatment are critical to a successful outcome for these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Advisory Committee on Heritable Disorders in Newborns and Children, Recommended Uniform Screening Panel. https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp/index.html. Accessed 30 Dec 2020.
Fabie NAV, Pappas KB, Feldman GL. The current state of newborn screening in the United States. Pediatr Clin N Am. 2019;66(2):369–86.
Saudubray JM, Garcia-Cazorla A. An overview of inborn errors of metabolism affecting the brain: from neurodevelopment to neurodegenerative disorders. Dialogues Clin Neurosci. 2018;20(4):301–25.
Reddy N, Calloni SF, Vernon HJ, Boltshauser E, Huisman TAGM, Soares BP. Neuroimaging findings of organic acidemias and aminoacidopathies. Radiographics. 2018;38(3):912–31.
Saudubray J-M, van den Berghe G, Walter JH. Inborn metabolic diseases: diagnosis and treatment. 5th ed. New York: Springer-Verlag Berlin Heidelberg; 2012.
Biotinidase WB. Deficiency. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2020. 2000 Mar 24 [Updated 2016 Jun 9]. https://www-ncbi-nlm-nih-gov.proxy.lib.wayne.edu/books/NBK1322/.
Larson A, Goodman S. Glutaric acidemia type 1. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. 2019 Sep 19. https://www-ncbi-nlm-nih-gov.proxy.lib.wayne.edu/books/NBK546575/.
Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.
Häberle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42(6):1192–230.
Spiekerkoetter U, Lindner M, Santer R, Grotzke M, Baumgartner MR, Boehles H, et al. Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis. 2009;32(4):488–97.
Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2015;17(9):689–701.
Aubourg P, Wanders R. Peroxisomal disorders. Handb Clin Neurol. 2013;113:1593–609.
Kanungo S, Wells K, Tribett T, El-Gharbawy A. Glycogen metabolism and glycogen storage disorders. Ann Transl Med. 2018;6(24):474.
Further Readings
Aliu E, Kanungo S, Arnold GL. Amino acid disorders. Ann Transl Med. 2018;6(24):471.
Aubourg P, Wanders R. Peroxisomal disorders. Handb Clin Neurol. 2013;113:1593–609.
Campistol J, Plecko B. Treatable newborn and infant seizures due to inborn errors of metabolism. Epileptic Disord. 2015;17(3):229–42.
Ebrahimi-Fakhari D, Van Karnebeek C, Münchau A. Movement disorders in treatable inborn errors of metabolism. Mov Disord. 2019;34(5):598–613.
Kanungo S, Wells K, Tribett T, El-Gharbawy A. Glycogen metabolism and glycogen storage disorders. Ann Transl Med. 2018;6(24):474.
Valayannopoulos V, Poll-The BT. Diagnostic work-up in acute conditions of inborn errors of metabolism and storage diseases. Handb Clin Neurol. 2013;113:1553–62.
van Karnebeek CD, Shevell M, Zschocke J, Moeschler JB, Stockler S. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. Mol Genet Metab. 2014;111(4):428–38.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pappas, K., Fabie, N.A.V., Feldman, G.L. (2022). Child with Suspected Metabolic Disorder. In: Kamat, D.M., Sivaswamy, L. (eds) Symptom-Based Approach to Pediatric Neurology . Springer, Cham. https://doi.org/10.1007/978-3-031-10494-7_33
Download citation
DOI: https://doi.org/10.1007/978-3-031-10494-7_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-10493-0
Online ISBN: 978-3-031-10494-7
eBook Packages: MedicineMedicine (R0)